|8-KFeb 26, 7:00 AM ET

IMMUNIC, INC. 8-K

Research Summary

AI-generated summary

Updated

IMMUNIC, Inc. Reports Q4 and Full-Year 2025 Results

What Happened

  • IMMUNIC, Inc. (ticker: IMUX) filed a Current Report on Form 8‑K on February 26, 2026 announcing its financial results for the quarter and year ended December 31, 2025. The company furnished a press release (Exhibit 99.1) that provides the reported quarterly results, full‑year results and a corporate update.
  • The 8‑K states the press release information is being furnished, not filed, and therefore is not subject to certain liabilities under the federal securities laws.

Key Details

  • Filing date: February 26, 2026.
  • Period covered: quarter and fiscal year ended December 31, 2025.
  • Press release furnished as Exhibit 99.1 to the Form 8‑K.
  • Legal note: the furnished information is not deemed “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other SEC filings (except where expressly stated).

Why It Matters

  • This 8‑K signals that IMMUNIC has released its latest earnings and corporate update; investors should review the full press release (Exhibit 99.1) or the company’s earnings materials for the specific revenue, earnings, and other financial metrics.
  • Because the information is furnished rather than filed, it carries the limited legal liability noted in the filing and won’t automatically become part of other SEC filings by reference. For formal financial statements and expanded disclosure, check the company’s subsequent filed reports (e.g., 10‑K or 10‑Q) or the detailed press release.